Stockscreener 앱 받기
1.02
3.03%
0.03
시장 영업 전:
1.00
-0.02
-1.96%
전일 마감가:
$0.99
열려 있는:
$0.99
하루 거래량:
66,446
Relative Volume:
0.45
시가총액:
$42.86M
수익:
-
순이익/손실:
$-32.00M
주가수익비율:
-0.672
EPS:
-1.5178
순현금흐름:
$-4.66M
1주 성능:
+0.00%
1개월 성능:
+2.36%
6개월 성능:
-28.67%
1년 성능:
-16.39%
1일 변동 폭
$0.9858
$1.03
1주일 범위
$0.976
$1.03
52주 변동 폭
$0.90
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
명칭
Mira Pharmaceuticals Inc
전화
813-369-5150
주소
1200 BRICKELL AVENUE, MIAMI
Compare MIRA vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.02 | 41.60M | 0 | -32.00M | -4.66M | -1.5178 |
LLY
Lilly Eli Co
|
989.87 | 862.31B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
224.26 | 533.03B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
207.86 | 358.27B | 62.82B | 3.60B | 19.98B | 2.0274 |
AZN
Astrazeneca Plc
|
184.54 | 282.04B | 60.48B | 10.40B | 8.05B | 3.3297 |
NVS
Novartis Ag Adr
|
148.16 | 277.11B | 54.66B | 13.58B | 16.05B | 7.0171 |
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
What's going on with MIRA Pharma stock Tuesday? - MSN
Is MIRA Pharmaceuticals (MIRA) stock hiding in plain sight? (Wavering) 2026-05-11Rating Change - newser.com
Number of shareholders of MIRA Pharmaceuticals, Inc. – NASDAQ:MIRA - TradingView
MIRA Pharmaceuticals (MIRA) Top Loser | Q3 2025: Profit SurprisesPost Earnings - UBND thành phố Hải Phòng
Should I buy MIRA Pharmaceuticals (MIRA) stock right now | Q3 2025: EPS Exceeds ExpectationsMargin of Safety - UBND thành phố Hải Phòng
MIRA Pharmaceuticals (MIRA) Stock: Momentum Analysis (Momentum Building) 2026-04-16Low Volatility Stocks - Xã Vĩnh Công
Stock List: Research Stocks from Around the World - GuruFocus
MIRA Stock Price, Quote & Chart | MIRA PHARMACEUTICALS INC (NASDAQ:MIRA) - ChartMill
Aug Summary: How does MIRA Pharmaceuticals Inc compare to its peersWeekly Investment Recap & AI Driven Stock Movement Reports - baoquankhu1.vn
Is MIRA Pharmaceuticals (MIRA) Stock Good for Active Traders | Price at $1.03, Down 4.63%Expert Entry Points - newser.com
MIRA Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings | K6S | US60458C1045 - marketscreener.com
MIRA Pharmaceuticals : Investor Presentation - marketscreener.com
MIRA Technical Analysis & Stock Price Forecast - Intellectia AI
MIRA completes Phase 1 trial of oral NMDA drug Ketamir-2 - Investing.com
MIRA Stock Analysis: MIRA Pharmaceuticals Inc. rises 4.72 pct to hold 1.11 level - Xã Thanh Hà
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Investment Report: How does MIRA Pharmaceuticals Inc compare to its peersPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - 富途牛牛
Mira Pharmaceuticals Inc (K6S.MU) stock price, news, quote and history - Yahoo Finance UK
MIRA Pharmaceuticals (MIRA) CEO granted 83,500 RSUs - Stock Titan
MIRA Should I Buy - Intellectia AI
Cash strain and trial progress at MIRA Pharmaceuticals (NASDAQ: MIRA) - Stock Titan
Mira Pharmaceuticals 10-K: $— Revenue, $(1.35) EPS, $(10.44)M Net Loss - tradingview.com
MIRA Pharmaceuticals | 10-K: FY2025 Annual Report - Moomoo
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
MIRA Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Institution Moves: Can MIRA Pharmaceuticals Inc deliver alphaWeekly Gains Summary & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Analyst Downgrade: What are MIRA Pharmaceuticals Incs recent SEC filings showing2026 WrapUp & Community Shared Stock Ideas - baoquankhu1.vn
Retail Surge: Is MIRA Pharmaceuticals Inc a strong growth stockMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
MIRA Pharmaceuticals, Inc.Common Stock (NQ:MIRA) - FinancialContent
What's Going On With MIRA Pharma Stock Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
MIRA’s Mira-55 shows no CNS side effects in preclinical tests By Investing.com - Investing.com India
MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55 - TipRanks
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies - The Desert Sun
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Mira Pharmaceuticals, Inc. Announces Positive Preclinical Results for Mira-55, a Non-Opioid Pain and Anxiety Treatment - Minichart
Mira Pharmaceuticals reports preclinical results for Mira-55 with no observed THC- or rimonabant-like CNS side effects - Investing.com India
MIRA’s Mira-55 shows no CNS side effects in preclinical tests - investing.com
Mira Pharmaceuticals Inc (MIRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.23%
자본화:
|
볼륨(24시간):